🇰🇷 Forzinity in South Korea

Forzinity (ELAMIPRETIDE) regulatory status in South Korea.

Marketing authorisation

MFDS

  • Marketing authorisation holder: STEALTH BIOTHERAPS
  • Status: likely_approved

Forzinity in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Cardiovascular approved in South Korea

Frequently asked questions

Is Forzinity approved in South Korea?

Yes. MFDS has authorised it.

Who is the marketing authorisation holder for Forzinity in South Korea?

STEALTH BIOTHERAPS holds the South Korean marketing authorisation.